NantBio
Culver City · Founded 2013
About NantBio
NantBio offers treatments by developing molecularly targeted drugs, based on the molecular profile of the patient’s tumor.
Company Facts
- Founded: 2013
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $182.1M
- Last round: Series Unknown (Feb 2024)
- Website: https://nantworks.com
- Phone: +1 310-853-7888
Industries & Categories
Biopharma, Biotechnology, Health Care, Wellness
Social Profiles
Canonical: https://fsome.com/organization/nantbio-126478 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.